145 related articles for article (PubMed ID: 35333927)
1. WGCNA and molecular docking reveal key hub genes and potential natural inhibitor in interstitial cystitis/bladder pain syndrome.
Li K; Lai C; Liu C; Li Z; Guo K; Xu K
Int Urogynecol J; 2022 Aug; 33(8):2241-2249. PubMed ID: 35333927
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the core genes in ulcerative interstitial cystitis/bladder pain syndrome.
Wu H; Su QX; Zhang ZY; Zhang Z; Gao SL; Lu C; Zuo L; Zhang LF
Int Braz J Urol; 2021; 47(4):843-855. PubMed ID: 33848079
[TBL] [Abstract][Full Text] [Related]
3. Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome.
Liu S; Feng S; Luo D
Int Urogynecol J; 2019 Sep; 30(9):1487-1495. PubMed ID: 30456462
[TBL] [Abstract][Full Text] [Related]
4. Identification of Immune-Related Genes and Small-Molecule Drugs in Interstitial Cystitis/Bladder Pain Syndrome Based on the Integrative Machine Learning Algorithms and Molecular Docking.
Jiang Y; Zhu X; Al-Danakh AY; Chen Q; Yang D
J Immunol Res; 2022; 2022():2069756. PubMed ID: 36619718
[TBL] [Abstract][Full Text] [Related]
5. Identification of key genes in human urothelial cells corresponding to interstitial cystitis/bladder pain syndrome in a lipopolysaccharide-induced cystitis model.
Peng L; Li BY; Wang W; Gao XS; Zeng X; Luo DY
Neurourol Urodyn; 2021 Sep; 40(7):1720-1729. PubMed ID: 34245600
[TBL] [Abstract][Full Text] [Related]
6. Identification of a potential structure-based GPCR drug for interstitial cystitis/bladder pain syndrome: in silico protein structure analysis and molecular docking.
Li K; Lai C; Hei S; Liu C; Li Z; Xu K
Int Urogynecol J; 2023 Jul; 34(7):1559-1565. PubMed ID: 36576541
[TBL] [Abstract][Full Text] [Related]
7. Identification of key pathways and mRNAs in interstitial cystitis/bladder pain syndrome treatment with quercetin through bioinformatics analysis of mRNA-sequence data.
Wang G; Li P; Su SW; Xu R; Huang ZY; Yang TX; Li JM
Aging (Albany NY); 2024 Mar; 16(7):5949-5966. PubMed ID: 38526326
[TBL] [Abstract][Full Text] [Related]
8. Analysis of ginseng in the treatment of Interstitial Cystitis/Bladder Pain Syndrome based on network pharmacology.
Wang L; Yuan L
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4709-4720. PubMed ID: 35856363
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics Approach for Identifying Novel Biomarkers and Their Signaling Pathways Involved in Interstitial Cystitis/Bladder Pain Syndrome with Hunner Lesion.
Saha SK; Jeon TI; Jang SB; Kim SJ; Lim KM; Choi YJ; Kim HG; Kim A; Cho SG
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575815
[TBL] [Abstract][Full Text] [Related]
10. miRNA-Gene Interaction Network Construction Strategy to Discern Promising Traditional Chinese Medicine against Osteoporosis.
Li L; Ayiding X; Han R
Biomed Res Int; 2022; 2022():9093614. PubMed ID: 35757478
[TBL] [Abstract][Full Text] [Related]
11. Bruton tyrosine kinase (BTK) may be a potential therapeutic target for interstitial cystitis/bladder pain syndrome.
Wang G; Yang TX; Li JM; Huang ZY; Yang WB; Li P; He DL
Aging (Albany NY); 2022 Sep; 14(17):7052-7064. PubMed ID: 36069808
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive transcriptome profiling of urothelial cells following TNFα stimulation in an
Kuret T; Peskar D; Kreft ME; Erman A; Veranič P
Front Immunol; 2022; 13():960667. PubMed ID: 36045687
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis of the Hub genes and key pathways of interstitial cystitis pathogenesis.
Liu J; Zhang Y; Li S; Sun F; Wang G; Wei D; Yang T; Gu S
Neurourol Urodyn; 2020 Jan; 39(1):133-143. PubMed ID: 31663162
[TBL] [Abstract][Full Text] [Related]
14. Study on the potential active components and molecular mechanism of Xiao Huoluo Pills in the treatment of cartilage degeneration of knee osteoarthritis based on bioinformatics analysis and molecular docking technology.
Chen W; Lin T; He Q; Yang P; Zhang G; Huang F; Wang Z; Peng H; Li B; Liang D; Wang H
J Orthop Surg Res; 2021 Jul; 16(1):460. PubMed ID: 34273999
[TBL] [Abstract][Full Text] [Related]
15. Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome.
Colaco M; Koslov DS; Keys T; Evans RJ; Badlani GH; Andersson KE; Walker SJ
J Urol; 2014 Oct; 192(4):1123-9. PubMed ID: 24840534
[TBL] [Abstract][Full Text] [Related]
16. Exploration and validation of hub genes and pathways in the progression of hypoplastic left heart syndrome via weighted gene co-expression network analysis.
Liu X; Shang H; Li B; Zhao L; Hua Y; Wu K; Hu M; Fan T
BMC Cardiovasc Disord; 2021 Jun; 21(1):300. PubMed ID: 34130651
[TBL] [Abstract][Full Text] [Related]
17. Using weighted gene co-expression network analysis (WGCNA) to identify the hub genes related to hypoxic adaptation in yak (Bos grunniens).
Bao Q; Zhang X; Bao P; Liang C; Guo X; Chu M; Yan P
Genes Genomics; 2021 Oct; 43(10):1231-1246. PubMed ID: 34338989
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of Tripterine Anti-Ovarian Cancer Effects Using Weighted Gene Co-Expression Network Analysis and Molecular Docking.
Long X; Liu L; Zhao Q; Xu X; Liu P; Zhang G; Lin J
Med Sci Monit; 2022 Jan; 28():e932139. PubMed ID: 35022380
[TBL] [Abstract][Full Text] [Related]
19. Co-expression modules construction by WGCNA and identify potential hub genes and regulation pathways of postpartum depression.
Deng Z; Cai W; Liu J; Deng A; Yang Y; Tu J; Yuan C; Xiao H; Gao W
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1019-1030. PubMed ID: 34856750
[No Abstract] [Full Text] [Related]
20. Integrated mRNA-miRNA transcriptome analysis of bladder biopsies from patients with bladder pain syndrome identifies signaling alterations contributing to the disease pathogenesis.
Gheinani AH; Akshay A; Besic M; Kuhn A; Keller I; Bruggmann R; Rehrauer H; Adam RM; Burkhard FC; Monastyrskaya K
BMC Urol; 2021 Dec; 21(1):172. PubMed ID: 34876093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
